Jae B. Kim - 24 Oct 2024 Form 3 Insider Report for Septerna, Inc. (SEPN)

Role
Chief Medical Officer
Signature
/s/ Ran Xiao, Attorney-in-Fact
Issuer symbol
SEPN
Transactions as of
24 Oct 2024
Net transactions value
$0
Form type
3
Filing time
24 Oct 2024, 21:37:14 UTC
Previous filing
20 Mar 2024
Next filing
11 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SEPN Stock Option (Right to Buy) 24 Oct 2024 Common Stock 185,823 $6.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest on September 24, 2025, with the remainder vesting in thirty-six substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney